[Skip to Content]
[Skip to Content Landing]
Views 306
Citations 0
Comment & Response
March 2017

Where Is the Geriatrician?

Author Affiliations
  • 1Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
  • 2Department of Geriatrics, Neurosciences and Orthopedics, Catholic University of the Sacred Heart School of Medicine, Rome, Italy
JAMA Intern Med. 2017;177(3):441-442. doi:10.1001/jamainternmed.2016.8853

To the Editor We have read with great interest the article by Munson and colleagues1 in a recent issue of JAMA Internal Medicine exploring the use of prescription drugs associated with fracture risk in patients with fragility fractures. At the time of fracture, about three-quarters of patients were receiving at least 1 drug associated with increased fracture risk. The prescription pattern did not substantially change following the fracture event.

First Page Preview View Large
First page PDF preview
First page PDF preview
×